Inogen Announces Fourth Quarter and Full Year 2017 Financial Results and Updates 2018 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Inogen, Inc (INGN) PT Raised to $150 at Needham & Company; Domestic B2B and DTC Sales Drive Results
February 28, 2018 7:17 AM ESTNeedham & Company raised its price target on Inogen, Inc (NASDAQ: INGN) to $150.00 (from $125.00) while maintaining a Strong Buy rating.
Analyst Mike Matson commented, "INGN beat consensus revenue, EBITDA, and EPS in 4Q17. Management raised its 2018 revenue and net income guidance and maintained its... More
Inogen (INGN) Posts Q4 Loss of $0.03, Revs Beat; Outlook Raised
February 27, 2018 4:39 PM ESTInogen (NASDAQ: INGN) reported Q4 EPS of ($0.03), $0.26 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $63.8 million versus the consensus estimate of $61.83 million.
GUIDANCE:
Inogen raised FY2018 revenue to $298-308 million, versus the consensus of $302.1... More
